Erasmus School of Health Policy & Management
External PhD candidate | Health Technology Assessment (HTA)
- cox@eshpm.eur.nl
More information
Work
- J. Cox, H. El Achaouch, M. Kuijper, A. E. A. M. Weel-Koenders & T. Bosch (2025) - Exploring Adalimumab Trough Levels and Disease Activity in Rheumatoid Arthritis the Radar Study - Annals of the rheumatic diseases, 83 (Supplement 1), 1556 - doi: 10.1136/annrheumdis-2024-eular.5543 - [link]
- Luuk van Esveld, Juul M Cox, T Martijn Kuijper, Tessa M Bosch & Angelique Eam Weel-Koenders (2023) - Cost-utility analysis of tapering strategies of biologicals in rheumatoid arthritis patients in the Netherlands - Annals of the rheumatic diseases, 82 (10), 1296-1306 - doi: 10.1136/ard-2023-224190 - [link]
- Juul M. Cox, Leni van Doorn, Ruben Malmberg, Esther Oomen-de Hoop, Tessa M. Bosch, Patricia M.L.A. van den Bemt, Ingrid A. Boere, Agnes Jager, Ron H.J. Mathijssen & Roelof W.F. van Leeuwen (2021) - The added value of H2 antagonists in premedication regimens during paclitaxel treatment - British Journal of Cancer, 124 (10), 1647-1652 - doi: 10.1038/s41416-021-01313-0 - [link]
